2m 2m 2m 2m 2m 2m 2m
ALX ONCOLOGY (ALXO)
NASDAQ
$1.22-$0.08 (-6.15%)
Price as of Oct 02, 2026 4:39 PM EDT- $179.8MMarket Cap
- -31.94%1-Year Change
- BiotechnologyIndustry
ALX ONCOLOGY (ALXO)
$1.22-$0.08 (-6.15%)
ALXO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.30 | ||
Change | -$0.09 (-6.47%) | ||
Open | $1.37 | ||
High | $1.42 | ||
Low | $1.28 | ||
Previous Close | $1.39 | ||
Volume | 1,481,501 | ||
30-Day Average Volume | 1,193,540 | ||
1-Week Change | -4.06% | ||
1-Month Change | -34.34% | ||
1-Year Change | -31.94% | ||
3-Year Change | -72.92% | ||
5-Year Change | -98.25% | ||
Fundamentals | |||
Shares Outstanding | 138.3M | ||
Total Assets | $160.8M | ||
Market Cap | $179.8M | ||
Enterprise Value | $166.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$17.7M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $128.7M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue